InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,982.40
(
-1.17%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.21
(
-0.08%
)
Bitcoin
60,957.07
(
1.15%
)
Post# of 252337
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

drbio45

Send PM Follow Ignore
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

drbio45

Re: erbse24448 post# 38876

Sunday, 12/10/2006 10:15:33 AM

Sunday, December 10, 2006 10:15:33 AM

Post# of 252337
PAION announces last patient randomized in Phase III ischemic strokestudy (DIAS-2) with Desmoteplase

If it didn't have the clinical hold for 2 days the stock would now be double what it is trading for.

As people get comfortable that the trial is fully enrolled and the data should be out in 4 to 5 months for a stroke drug that could increase the window of therapy from 3 to 9 hours or more interest should get generated
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up